Advertisement

Journal of Natural Medicines

, Volume 69, Issue 2, pp 241–248 | Cite as

Antifungal activity of the essential oil of Angelica major against Candida, Cryptococcus, Aspergillus and dermatophyte species

  • Carlos Cavaleiro
  • Lígia Salgueiro
  • Maria-José Gonçalves
  • Karnjana Hrimpeng
  • Jéssica Pinto
  • Eugénia PintoEmail author
Original Paper

Abstract

The composition and antifungal activity of the essential oil (EO) of Angelica major and its main components α-pinene and cis-β-ocimene against clinically relevant yeasts and moulds were evaluated. EO from the plant’s aerial parts was obtained by hydrodistillation and analysed by gas chromatography (GC) and gas chromatography/mass spectrometry (GC/MS). The oil showed high contents of α-pinene (21.8 %) and cis-β-ocimene (30.4 %). Minimum inhibitory concentrations (MICs) were measured according to the broth macrodilution protocols by the Clinical and Laboratory Standards Institute (CLSI). The EO, α-pinene and cis-β-ocimene displayed low MICs and minimum fungicidal concentrations (MFCs) against dermatophytes and Cryptococcus neoformans, with α-pinene being the most active. Regarding Candida species, the EO susceptibility profiles seem to be diverse and not correlated with fluconazole susceptibility patterns. Moreover, an inhibition of yeast–mycelium transition was demonstrated at sub-inhibitory concentrations of the EO, α-pinene and cis-β-ocimene in C. albicans. In addition, their haemolytic activity was low. The activity displayed by A. major EO and its main components associated with low cytotoxic activity confirms their potential as an antifungal agent against fungal species frequently implicated in human mycoses, particularly cryptococcosis and dermatophytosis. The association with commercial antifungal compounds could bring benefits, by the effect on germ tube formation, and be used in mucocutaneous candidiasis treatment.

Keywords

Angelica major Volatile oil Antifungal activity Inhibition of yeast–mycelium transition Haemolytic activity 

Notes

Acknowledgements

The authors are grateful to Fundação para a Ciência e a Tecnologia (FCT) through grants PEst-OE/SAU/UI0177/2011 and CEQUIMED-PEst-OE/SAU/UI4040/2014.

The Microbiology Department, Faculty of Science, Burapha University, Thailand is acknowledged for collaboration with the Lotus—Erasmus Mundus Action Two Partnership (EMA2) of European and South-East Asian Higher Education Institutions (HEI).

Thanks are also due to Dra Ana Cristina Tavares (CEF/Faculty of Pharmacy, University of Coimbra) for her help in prospecting plant material.

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Richardson M, Lass-Flörl C (2008) Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 14:5–24CrossRefPubMedGoogle Scholar
  2. 2.
    Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503–535CrossRefPubMedGoogle Scholar
  3. 3.
    Achkar JM, Fries BC (2010) Candida infections of the genitourinary tract. Clin Microbiol Rev 23:253–273CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    de Pauw BE, Picazo JJ (2008) Present situation in the treatment of invasive fungal infection. Int J Antimicrob Agents 32:S167–S171CrossRefPubMedGoogle Scholar
  5. 5.
    Pfaller MA (2012) Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3–S13CrossRefPubMedGoogle Scholar
  6. 6.
    Denning DW, Hope WW (2010) Therapy for fungal diseases: opportunities and priorities. Trends Microbiol 18:195–204CrossRefPubMedGoogle Scholar
  7. 7.
    Rapp RP (2004) Changing strategies for the management of invasive fungal infections. Pharmacotherapy 24:4S–28SCrossRefPubMedGoogle Scholar
  8. 8.
    Ekiert H (2000) Medicinal plant biotechnology: the Apiaceae family as the example of rapid development. Pharmazie 55:561–567PubMedGoogle Scholar
  9. 9.
    Castroviejo S (2003) Flora Ibérica, vol X. CSIC, MadridGoogle Scholar
  10. 10.
    Council of Europe (1997) European pharmacopoeia, 3rd edn. Council of Europe, StrasbourgGoogle Scholar
  11. 11.
    Joulain D, Koenig WA (1998) The atlas of spectral data of sesquiterpene hydrocarbons. E.B.-Verlag, HamburgGoogle Scholar
  12. 12.
    Adams RP (2004) Identification of essential oil components by gas chromatography/quadrupole mass spectroscopy. Allured Publishing Corporation, Carol StreamGoogle Scholar
  13. 13.
    Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard—Third edition. CLSI document M27-A3. CLSI, WayneGoogle Scholar
  14. 14.
    Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Informational supplement—Third edition. CLSI document M27-S3. CLSI, WayneGoogle Scholar
  15. 15.
    Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; Approved standard—Second edition. CLSI document M38–A2. CLSI, WayneGoogle Scholar
  16. 16.
    Marichal P, Gorrens J, Van Cutsem J, Vanden Bossche H (1986) Culture media for the study of the effects of azole derivatives on germ tube formation and hyphal growth of C. albicans. Mykosen 29:76–81CrossRefPubMedGoogle Scholar
  17. 17.
    Ahmad A, Khan A, Manzoor N, Khan LA (2010) Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microb Pathog 48:35–41CrossRefPubMedGoogle Scholar
  18. 18.
    Saville SP, Lazzell AL, Bryant AP, Fretzen A, Monreal A, Solberg EO, Monteagudo C, Lopez-Ribot JL, Milne GT (2006) Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrob Agents Chemother 50:3312–3316CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Nivinskienë O, Butkienë R, Mockutë D (2003) Changes in the chemical composition of essential oil of Angelica archangelica L. roots during storage. Chemija (Vilnius) 14:52–56Google Scholar
  20. 20.
    Kerrola K, Galambosi B, Kallio H (1994) Characterization of volatile composition and odor of angelica (Angelica archangelica subsp. archangelica L.) root extracts. J Agric Food Chem 42:1979–1988CrossRefGoogle Scholar
  21. 21.
    Agnihotri VK, Thappa RK, Meena B, Kapahi BK, Saxena RK, Qazi GN, Agarwal SG (2004) Essential oil composition of aerial parts of Angelica glauca growing wild in North-West Himalaya (India). Phytochemistry 65:2411–2413CrossRefPubMedGoogle Scholar
  22. 22.
    Seo HY, Yang SH, Shim SL, No KM, Park KS, Song KD, Kim KS (2007) Volatile organic compounds of Angelica gigas Nakai, Korean medicinal herb. Nat Prod Res 21:265–273CrossRefPubMedGoogle Scholar
  23. 23.
    Mendes MD, Trindade H, Figueiredo AC, Barroso JG, Fontinha SS, Pedro LG (2009) Volatile and molecular characterization of two Portuguese endemic species: Angelica lignescens and Melanoselinum decipiens. Biochem Syst Ecol 37:98–105CrossRefGoogle Scholar
  24. 24.
    Zuzarte M, Vale-Silva L, Gonçalves MJ, Cavaleiro C, Vaz S, Canhoto J, Pinto E, Salgueiro L (2012) Antifungal activity of phenolic-rich Lavandula multifida L. essential oil. Eur J Clin Microbiol Infect Dis 31:1359–1366CrossRefPubMedGoogle Scholar
  25. 25.
    Pinto E, Hrimpeng K, Lopes G, Vaz S, Gonçalves MJ, Cavaleiro C, Salgueiro L (2013) Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species. Eur J Clin Microbiol Infect Dis 32:1311–1320CrossRefPubMedGoogle Scholar
  26. 26.
    Zuzarte M, Gonçalves MJ, Cavaleiro C, Canhoto J, Vale-Silva L, Silva MJ, Pinto E, Salgueiro L (2011) Chemical composition and antifungal activity of the essential oils of Lavandula viridis L’Hér. J Med Microbiol 60:612–618CrossRefPubMedGoogle Scholar
  27. 27.
    Cavaleiro C, Pinto E, Gonçalves MJ, Salgueiro L (2006) Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. J Appl Microbiol 100:1333–1338CrossRefPubMedGoogle Scholar
  28. 28.
    Gupta AK, Cooper EA (2008) Update in antifungal therapy of dermatophytosis. Mycopathologia 166:353–367CrossRefPubMedGoogle Scholar
  29. 29.
    Tavares AC, Gonçalves MJ, Cruz MT, Cavaleiro C, Lopes MC, Canhoto J, Salgueiro LR (2010) Essential oils from Distichoselinum tenuifolium: chemical composition, cytotoxicity, antifungal and anti-inflammatory properties. J Ethnopharmacol 130:593–598CrossRefPubMedGoogle Scholar
  30. 30.
    Rivas da Silva AC, Lopes PM, Barros de Azevedo MM, Costa DC, Alviano CS, Alviano DS (2012) Biological activities of α-pinene and β-pinene enantiomers. Molecules 17:6305–6316CrossRefPubMedGoogle Scholar
  31. 31.
    Nissen L, Zatta A, Stefanini I, Grandi S, Sgorbati B, Biavati B, Monti A (2010) Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.). Fitoterapia 81:413–419CrossRefPubMedGoogle Scholar
  32. 32.
    Filipowicz N, Kamiński M, Kurlenda J, Asztemborska M, Ochocka JR (2003) Antibacterial and antifungal activity of juniper berry oil and its selected components. Phytother Res 17:227–231CrossRefPubMedGoogle Scholar
  33. 33.
    Mitchell AP (1998) Dimorphism and virulence in Candida albicans. Curr Opin Microbiol 1:687–692CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Pharmacognosy and Springer Japan 2015

Authors and Affiliations

  • Carlos Cavaleiro
    • 1
  • Lígia Salgueiro
    • 1
  • Maria-José Gonçalves
    • 1
  • Karnjana Hrimpeng
    • 2
    • 3
  • Jéssica Pinto
    • 2
  • Eugénia Pinto
    • 2
    • 4
    Email author
  1. 1.Faculty of Pharmacy/CEF and CNCUniversity of CoimbraCoimbraPortugal
  2. 2.CEQUIMED-UP, Microbiology Service, Biological Sciences Department, Faculty of PharmacyUniversity of PortoPortoPortugal
  3. 3.Microbiology Department, Faculty of ScienceBurapha UniversityChonburiThailand
  4. 4.CIIMAR/CIMAR, Centro Interdisciplinar de Investigação Marinha e AmbientalUniversidade do PortoPortoPortugal

Personalised recommendations